High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  ACS Nano

• Publication date

  2013-11-26

• Fields of study

  Medicine, Materials Science, Engineering

• Identifiers
  DOI 10.1021/nn4035316PMID 24131405PMCID PMC3868485
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhancing Chemotherapy Response with Sustained EphA2 Silencing Using Multistage Vector Delivery

  2013cited by this paper
• Multistage vectored siRNA targeting ataxia-telangiectasia mutated for breast cancer therapy.

  2013cited by this paper
• MicroRNA-18a upregulates autophagy and ataxia telangiectasia mutated gene expression in HCT116 colon cancer cells.

  2013cited by this paper
• Expanding the Number of ‘Druggable’ Targets: Non‐Enzymes and Protein–Protein Interactions

  2013cited by this paper
• Cooperative, Nanoparticle‐Enabled Thermal Therapy of Breast Cancer

  2012cited by this paper
• Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution.

  2012cited by this paper
• Supramolecular assemblies in functional siRNA delivery: where do we stand?

  2012cited by this paper
• The many faces of Janus kinase.

  2012cited by this paper
• Nanovector delivery of siRNA for cancer therapy

  2012cited by this paper
• Discoidal Porous Silicon Particles: Fabrication and Biodistribution in Breast Cancer Bearing Mice

  2012cited by this paper
• The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors.

  2011cited by this paper
• Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast

  2010cited by this paper
• Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

  2010cited by this paper
• Size and shape effects in the biodistribution of intravascularly injected particles.

  2010cited by this paper
• Sustained small interfering RNA delivery by mesoporous silicon particles.

  2010cited by this paper
• Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

  2008cited by this paper
• Cancer Proliferation Gene Discovery Through Functional Genomics

  2008cited by this paper
• The Genomic Landscapes of Human Breast and Colorectal Cancers

  2007cited by this paper
• let-7 regulates self renewal and tumorigenicity of breast cancer cells.

  2007cited by this paper
• Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity.

  2006cited by this paper
• Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7

  2005cited by this paper
• Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA

  2005cited by this paper
• Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

  2005cited by this paper
• Therapeutic implications of cancer stem cells.

  2004cited by this paper
• Conjugation to gold nanoparticles enhances polyethylenimine's transfer of plasmid DNA into mammalian cells

  2003cited by this paper
• Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes*

  2003cited by this paper
• New genes involved in cancer identified by retroviral tagging

  2002cited by this paper
• ER stress regulation of ATF6 localization by dissociation of BiP/GRP78 binding and unmasking of Golgi localization signals.

  2002cited by this paper
• The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting.

  2001cited by this paper
• Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

  2001cited by this paper
• Leukaemia disease genes: large-scale cloning and pathway predictions

  1999cited by this paper
• Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

  1998cited by this paper
• Lipopolysaccharide-induced lethality and cytokine production in aged mice

  1996cited by this paper
• A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

  1986cited by this paper

• Advancing Targeted Therapies in Pancreatic Cancer: Leveraging Molecular Aberrations for Therapeutic Success.

  2025cites this paper
• Silicon-containing nanomedicine and biomaterials: materials chemistry, multi-dimensional design, and biomedical application.

  2024cites this paper
• Milling efficiency and wear behavior of silicon grinding media in autogenous stirred media milling

  2024cites this paper
• Porous silicon-based sensing and delivery platforms for wound management applications.

  2024cites this paper
• Biomaterials Facilitating Dendritic Cell‐Mediated Cancer Immunotherapy

  2023cites this paper
• Biolistic Delivery of Photosensitizer‐Loaded Porous Si Carriers for Localized Photodynamic Therapy

  2023cites this paper
• Colorectal cancer cell membrane biomimetic ferroferric oxide nanomaterials for homologous bio-imaging and chemotherapy application

  2023cites this paper
• Smart gating membrane based on polyzwitterion-modified SiO2 nanoparticles for water treatment and in-situ multi-modal detection

  2023cites this paper
• Porcine Epidemic Diarrhea Virus and Its nsp14 Suppress ER Stress Induced GRP78

  2023cites this paper
• Aggregation-Induced Emission Photosensitizer Synergizes Photodynamic Therapy and the Inhibition of the NF-κB Signaling Pathway to Overcome Hypoxia in Breast Cancer.

  2022cites this paper
• Polymeric Carriers for Delivery of RNA Cancer Therapeutics

  2022cites this paper
• Porous Silicon Nanoparticles Targeted to the Extracellular Matrix for Therapeutic Protein Delivery in Traumatic Brain Injury.

  2022cites this paper
• Nanoimmunoengineering strategies in cancer diagnosis and therapy

  2022cites this paper
• Ofloxacin@Doxorubicin-Epirubicin functionalized MCM-41 mesoporous silica-based nanocarriers as synergistic drug delivery tools for cancer related bacterial infections.

  2021cites this paper
• Recent advances in surface engineering of porous silicon nanomaterials for biomedical applications

  2021cites this paper
• Advances in cancer theranostics using organic-inorganic hybrid nanotechnology

  2021cites this paper
• Hybrid mesoporous nanoparticles with highly integrated polydopamine for pH-responsive membrane permeation and drug delivery

  2021cites this paper
• Synchronous conjugation of i-motif DNA and therapeutic siRNA on the vertexes of tetrahedral DNA nanocages for efficient gene silence

  2021cites this paper
• Rad51 Silencing with siRNA Delivered by Porous Silicon-Based Microparticle Enhances the Anti-Cancer Effect of Doxorubicin in Triple-Negative Breast Cancer.

  2021cites this paper
• Design of polymers for siRNA delivery: Recent progress and challenges

  2021cites this paper
• Artificial peptides for antitumoral siRNA delivery.

  2020cites this paper
• Liposome-Embedding Silicon Microparticle for Oxaliplatin Delivery in Tumor Chemotherapy

  2020cites this paper
• Multifunctional magnetic iron oxide nanoparticles: an advanced platform for cancer theranostics

  2020cites this paper
• Study of PLGA microspheres loaded with pOsx/PEI nanoparticles for repairing bone defects in vivo and in vitro.

  2020cites this paper
• Molecular Chaperones in Cancer Stem Cells: Determinants of Stemness and Potential Targets for Antitumor Therapy

  2020cites this paper
• Tumor-Targeting, MicroRNA-Silencing Porous Silicon Nanoparticles for Ovarian Cancer Therapy.

  2019cites this paper
• Biocompatible Fluorescent Silicon Nanoparticles for Imaging ‐ Guided Co ‐ Delivery of siRNA and Doxorubicin to Drug ‐ Resistant Cancer Cells

  2019cites this paper
• Title Tumor-Targeting , MicroRNA-Silencing Porous Silicon Nanoparticles for Ovarian Cancer Therapy

  2019cites this paper
• Photoluminescent and biodegradable porous silicon nanoparticles for biomedical imaging.

  2019cites this paper
• Silica-Based Mucosal Nanovaccines

  2019cites this paper
• DNA complexes as an efficient gene anticancer drug delivery therapy

  2019cites this paper
• Systematic comparison of methods for determining the in vivo biodistribution of porous nanostructured injectable inorganic particles.

  2019cites this paper
• Cancer stem cells and nanotechnological approaches for eradication.

  2019cites this paper
• Therapeutic Potential of the microRNA-ATM Axis in the Management of Tumor Radioresistance.

  2019cites this paper
• Hierarchical Nanostructuring of Porous Silicon with Electrochemical and Regenerative Electroless Etching.

  2019cites this paper
• Biocompatible and biodegradable inorganic nanostructures for nanomedicine: Silicon and black phosphorus

  2019cites this paper
• Clinical Cancer Nanomedicine.

  2019cites this paper
• Investigation of parameters that determine Nano-DC vaccine transport

  2019cites this paper
• Organotropic drug delivery: Synthetic nanoparticles and extracellular vesicles

  2019cites this paper
• Simultaneous delivery of gene and chemotherapeutics via copolymeric micellar nanoparticles to overcome multiple drug resistance to promote synergistic tumor suppression

  2019cites this paper
• Tracking Biodistribution of Myeloid-Derived Cells in Murine Models of Breast Cancer

  2019cites this paper
• Photostable and Biocompatible Fluorescent Silicon Nanoparticles for Imaging-Guided Co-Delivery of siRNA and Doxorubicin to Drug-Resistant Cancer Cells

  2019cites this paper
• Interfacially active polydopamine for nanoparticle stabilized nanocapsules in a one-pot assembly strategy toward efficient drug delivery.

  2018cites this paper
• Co‐delivery of tumor antigen and dual toll‐like receptor ligands into dendritic cell by silicon microparticle enables efficient immunotherapy against melanoma

  2018cites this paper
• Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy

  2018cites this paper
• Nanomaterials for Cancer Precision Medicine

  2018cites this paper
• Engineering functional inorganic-organic hybrid systems: advances in siRNA therapeutics.

  2018cites this paper
• Antibiotic-loaded nanoparticles targeted to the site of infection enhance antibacterial efficacy

  2018cites this paper
• Chemotherapy Sensitizes Therapy-Resistant Cells to Mild Hyperthermia by Suppressing Heat Shock Protein 27 Expression in Triple-Negative Breast Cancer

  2018cites this paper
• Tracking the Fate of Porous Silicon Nanoparticles Delivering a Peptide Payload by Intrinsic Photoluminescence Lifetime

  2018cites this paper
• Trends towards Biomimicry in Theranostics

  2018cites this paper
• Solvent Loading of Porous Silicon

  2018cites this paper
• Advances in Porous Silicon–Based Nanomaterials for Diagnostic and Therapeutic Applications

  2018cites this paper
• Synthetic materials at the forefront of gene delivery

  2018cites this paper
• Nanomaterial-based cancer immunotherapy

  2017cites this paper
• siRNA-nanoparticle conjugate in gene silencing: A future cure to deadly diseases?

  2017cites this paper
• Degradability and Clearance of Silicon, Organosilica, Silsesquioxane, Silica Mixed Oxide, and Mesoporous Silica Nanoparticles

  2017cites this paper
• A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery

  2017cites this paper
• A Liposome Encapsulated Ruthenium Polypyridine Complex as a Theranostic Platform for Triple-Negative Breast Cancer.

  2017cites this paper
• Post-nano strategies for drug delivery: Multistage porous silicon microvectors.

  2017cites this paper
• Multi-step encapsulation of chemotherapy and gene silencing agents in functionalized mesoporous silica nanoparticles.

  2017cites this paper
• Se/Ru-Decorated Porous Metal-Organic Framework Nanoparticles for The Delivery of Pooled siRNAs to Reversing Multidrug Resistance in Taxol-Resistant Breast Cancer Cells.

  2017cites this paper
• Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma.

  2017cites this paper
• A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo

  2017cites this paper
• Efficient in vivo siRNA delivery by stabilized d -peptide-based lipid nanoparticles

  2017cites this paper
• Integration of polymers in the pore space of mesoporous nanocarriers for drug delivery.

  2017cites this paper
• Nanoformulations for Pharmacological siRNA Delivery in Cancer

  2017cites this paper
• Porous Silicon Nanoparticle Delivery of Tandem Peptide Anti‐Infectives for the Treatment of Pseudomonas aeruginosa Lung Infections

  2017cites this paper
• Hesperetin Liposomes for Cancer Therapy.

  2016cites this paper
• Silicon Nanoparticles and Microparticles

  2016cites this paper
• Delivery of Flightless I siRNA from Porous Silicon Nanoparticles Improves Wound Healing in Mice.

  2016cites this paper
• Near‐Infrared Light‐Triggered Intracellular Delivery of Anticancer Drugs Using Porous Silicon Nanoparticles Conjugated with IR820 Dyes

  2016cites this paper
• Nanoparticle delivery systems for siRNA-based therapeutics.

  2016cites this paper
• MicroRNAs in Breast Cancer and Their Value as Biomarkers

  2016cites this paper
• An overview on the role of silica-based materials in vaccine development

  2016cites this paper
• Nanomedicine Activities in the United States and Worldwide

  2016cites this paper
• A specifically designed nanoconstruct associates, internalizes, traffics in cardiovascular cells, and accumulates in failing myocardium: a new strategy for heart failure diagnostics and therapeutics

  2016cites this paper
• Neoangiogenesis of human mesenchymal stem cells transfected with peptide-loaded and gene-coated PLGA nanoparticles.

  2016cites this paper
• Recent Advances in Discovering the Role of CCL5 in Metastatic Breast Cancer.

  2016cites this paper
• A pyruvate decarboxylase-mediated therapeutic strategy for mimicking yeast metabolism in cancer cells.

  2016cites this paper
• Ammonium salt modified mesoporous silica nanoparticles for dual intracellular-responsive gene delivery.

  2016cites this paper
• Enzyme-responsive multistage vector for drug delivery to tumor tissue.

  2016cites this paper
• Small interfering RNA delivery by polyethylenimine-functionalised porous silicon nanoparticles.

  2015cites this paper
• Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy.

  2015cites this paper
• Porous silicon for cancer therapy: from fundamental research to the clinic

  2015cites this paper
• Nanobiotechnology for the Therapeutic Targeting of Cancer Cells in Blood

  2015cites this paper
• Multistage vector delivery of sulindac and silymarin for prevention of colon cancer.

  2015cites this paper
• Biodistribution and Trafficking of Hydrogel Nanoparticles in Adult Mosquitoes

  2015cites this paper
• Chemical surface modification of porous silicon nanoparticles for cancer therapy

  2015cites this paper
• Self-Assembling Monomeric Nucleoside Molecular Nanoparticles Loaded with 5-FU Enhancing Therapeutic Efficacy against Oral Cancer.

  2015cites this paper
• Multistage vector (MSV) therapeutics.

  2015cites this paper
• Porous silicon microparticles for delivery of siRNA therapeutics.

  2015cites this paper
• Porous silicon microparticle potentiates anti-tumor immunity by enhancing cross-presentation and inducing type I interferon response.

  2015cites this paper
• The Biological Applications of Inorganic Nanoparticle Drug Carriers

  2015cites this paper
• Chitosan layered gold nanorods as synergistic therapeutics for photothermal ablation and gene silencing in triple-negative breast cancer.

  2015cites this paper
• Multistage Nanovectors Enhance the Delivery of Free and Encapsulated Drugs.

  2015cites this paper
• Safety of Nanoparticles in Medicine.

  2015cites this paper
• MicroRNA-mediated immune modulation as a therapeutic strategy in host-implant integration.

  2015cites this paper
• Physicochemical properties affect the synthesis, controlled delivery, degradation and pharmacokinetics of inorganic nanoporous materials.

  2015cites this paper
• Silicon-Based Nanoagents for Cancer Therapy

  2014cites this paper